K. Heinrich

Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist

M. Schroff, B. Wittig, Manuel Schmidt, 2016, Molecular therapy oncolytics.

Approaches to Dendritic Cell‐Based Immunotherapy after Peripheral Blood Stem Cell Transplantation

L. Kanz, W. Brugger, P. Brossart, 1999, Annals of the New York Academy of Sciences.

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.

H. Rammensee, S. Stevanović, L. Kanz, 1999, Blood.